doi: 10.1016/0019-2791(76)90344-x.
Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids
- PMID: 59690
- DOI: 10.1016/0019-2791(76)90344-x
Item in Clipboard
Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids
Immunochemistry.
1976 Apr.
No abstract available
Similar articles
-
Experimental allergic encephalomyelitis--susceptibility and suppression.Immunol Rev. 1981;55:5-30. doi: 10.1111/j.1600-065x.1981.tb00337.x. Immunol Rev. 1981. PMID: 6165673 Review. No abstract available.
-
Protection against experimental allergic encephalomyelitis.Nature. 1972 Dec 29;240(5383):564-6. doi: 10.1038/240564b0. Nature. 1972. PMID: 4119624 No abstract available.
-
Experimental allergic encephalomyelitis (EAE).Neurosci Res Program Bull. 1971 Sep;9(4):499-502. Neurosci Res Program Bull. 1971. PMID: 4133364 No abstract available.
-
Antigen-induced suppression of mitogen responses and resistance to experimental autoimmune encephalomyelitis.Cell Immunol. 1983 May;78(1):43-55. doi: 10.1016/0008-8749(83)90258-7. Cell Immunol. 1983. PMID: 6189624
-
The spinal cord protein (SCP): appraisal of physiological and immunological hypotheses of anti-encephalitogenic action.Immunochemistry. 1978 Nov;15(10-11):767-75. doi: 10.1016/0161-5890(78)90107-4. Immunochemistry. 1978. PMID: 85602 Review. No abstract available.
Cited by
-
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000. CNS Drugs. 2011. PMID: 21476611 Free PMC article. Review.
-
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis.Front Immunol. 2021 Jan 18;11:603029. doi: 10.3389/fimmu.2020.603029. eCollection 2020. Front Immunol. 2021. PMID: 33537031 Free PMC article.
-
Suppression and treatment of experimental allergic encephalitis in guinea-pigs with the bovine spinal cord protein (BSCP).Immunology. 1980 Jul;40(3):377-83. Immunology. 1980. PMID: 6159309 Free PMC article.
-
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm. 2021 Mar 11;8(3):e980. doi: 10.1212/NXI.0000000000000980. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33707177 Free PMC article. Clinical Trial.
-
Pathophysiology of multiple sclerosis.J Neurol. 2008 Dec;255 Suppl 6:2-6. doi: 10.1007/s00415-008-6001-2. J Neurol. 2008. PMID: 19300953 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
